2024-04-012025-03-312025-03-31false14178937PRIMARY CARE DEVELOPMENT HARINGEY LTD2025-12-04falseiso4217:GBPxbrli:pure141789372024-03-31141789372025-03-31141789372024-04-012025-03-31141789372023-06-30141789372024-03-31141789372023-07-012024-03-3114178937bus:SmallEntities2024-04-012025-03-3114178937bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3114178937bus:AbridgedAccounts2024-04-012025-03-3114178937bus:CompanyLimitedByGuarantee2024-04-012025-03-3114178937core:WithinOneYear2025-03-3114178937core:AfterOneYear2025-03-3114178937core:WithinOneYear2024-03-3114178937core:AfterOneYear2024-03-3114178937core:ShareCapital2025-03-3114178937core:SharePremium2025-03-3114178937core:RevaluationReserve2025-03-3114178937core:OtherReservesSubtotal2025-03-3114178937core:RetainedEarningsAccumulatedLosses2025-03-3114178937core:ShareCapital2024-03-3114178937core:SharePremium2024-03-3114178937core:RevaluationReserve2024-03-3114178937core:OtherReservesSubtotal2024-03-3114178937core:RetainedEarningsAccumulatedLosses2024-03-3114178937core:LandBuildings2025-03-3114178937core:PlantMachinery2025-03-3114178937core:Vehicles2025-03-3114178937core:FurnitureFittings2025-03-3114178937core:OfficeEquipment2025-03-3114178937core:NetGoodwill2025-03-3114178937core:IntangibleAssetsOtherThanGoodwill2025-03-3114178937core:ListedExchangeTraded2025-03-3114178937core:UnlistedNon-exchangeTraded2025-03-3114178937core:LandBuildings2024-03-3114178937core:PlantMachinery2024-03-3114178937core:Vehicles2024-03-3114178937core:FurnitureFittings2024-03-3114178937core:OfficeEquipment2024-03-3114178937core:NetGoodwill2024-03-3114178937core:IntangibleAssetsOtherThanGoodwill2024-03-3114178937core:ListedExchangeTraded2024-03-3114178937core:UnlistedNon-exchangeTraded2024-03-3114178937core:LandBuildings2024-04-012025-03-3114178937core:PlantMachinery2024-04-012025-03-3114178937core:Vehicles2024-04-012025-03-3114178937core:FurnitureFittings2024-04-012025-03-3114178937core:OfficeEquipment2024-04-012025-03-3114178937core:NetGoodwill2024-04-012025-03-3114178937core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114178937core:ListedExchangeTraded2024-04-012025-03-3114178937core:UnlistedNon-exchangeTraded2024-04-012025-03-3114178937core:MoreThanFiveYears2024-04-012025-03-3114178937core:Non-currentFinancialInstruments2025-03-3114178937core:Non-currentFinancialInstruments2024-03-3114178937dpl:CostSales2024-04-012025-03-3114178937dpl:DistributionCosts2024-04-012025-03-3114178937core:LandBuildings2024-04-012025-03-3114178937core:PlantMachinery2024-04-012025-03-3114178937core:Vehicles2024-04-012025-03-3114178937core:FurnitureFittings2024-04-012025-03-3114178937core:OfficeEquipment2024-04-012025-03-3114178937dpl:AdministrativeExpenses2024-04-012025-03-3114178937core:NetGoodwill2024-04-012025-03-3114178937core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3114178937dpl:GroupUndertakings2024-04-012025-03-3114178937dpl:ParticipatingInterests2024-04-012025-03-3114178937dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3114178937core:ListedExchangeTraded2024-04-012025-03-3114178937dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3114178937core:UnlistedNon-exchangeTraded2024-04-012025-03-3114178937dpl:CostSales2023-07-012024-03-3114178937dpl:DistributionCosts2023-07-012024-03-3114178937core:LandBuildings2023-07-012024-03-3114178937core:PlantMachinery2023-07-012024-03-3114178937core:Vehicles2023-07-012024-03-3114178937core:FurnitureFittings2023-07-012024-03-3114178937core:OfficeEquipment2023-07-012024-03-3114178937dpl:AdministrativeExpenses2023-07-012024-03-3114178937core:NetGoodwill2023-07-012024-03-3114178937core:IntangibleAssetsOtherThanGoodwill2023-07-012024-03-3114178937dpl:GroupUndertakings2023-07-012024-03-3114178937dpl:ParticipatingInterests2023-07-012024-03-3114178937dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-03-3114178937core:ListedExchangeTraded2023-07-012024-03-3114178937dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-03-3114178937core:UnlistedNon-exchangeTraded2023-07-012024-03-3114178937core:NetGoodwill2025-03-3114178937core:IntangibleAssetsOtherThanGoodwill2025-03-3114178937core:LandBuildings2025-03-3114178937core:PlantMachinery2025-03-3114178937core:Vehicles2025-03-3114178937core:FurnitureFittings2025-03-3114178937core:OfficeEquipment2025-03-3114178937core:AfterOneYear2025-03-3114178937core:WithinOneYear2025-03-3114178937core:ListedExchangeTraded2025-03-3114178937core:UnlistedNon-exchangeTraded2025-03-3114178937core:ShareCapital2025-03-3114178937core:SharePremium2025-03-3114178937core:RevaluationReserve2025-03-3114178937core:OtherReservesSubtotal2025-03-3114178937core:RetainedEarningsAccumulatedLosses2025-03-3114178937core:NetGoodwill2024-03-3114178937core:IntangibleAssetsOtherThanGoodwill2024-03-3114178937core:LandBuildings2024-03-3114178937core:PlantMachinery2024-03-3114178937core:Vehicles2024-03-3114178937core:FurnitureFittings2024-03-3114178937core:OfficeEquipment2024-03-3114178937core:AfterOneYear2024-03-3114178937core:WithinOneYear2024-03-3114178937core:ListedExchangeTraded2024-03-3114178937core:UnlistedNon-exchangeTraded2024-03-3114178937core:ShareCapital2024-03-3114178937core:SharePremium2024-03-3114178937core:RevaluationReserve2024-03-3114178937core:OtherReservesSubtotal2024-03-3114178937core:RetainedEarningsAccumulatedLosses2024-03-3114178937core:NetGoodwill2023-06-3014178937core:IntangibleAssetsOtherThanGoodwill2023-06-3014178937core:LandBuildings2023-06-3014178937core:PlantMachinery2023-06-3014178937core:Vehicles2023-06-3014178937core:FurnitureFittings2023-06-3014178937core:OfficeEquipment2023-06-3014178937core:AfterOneYear2023-06-3014178937core:WithinOneYear2023-06-3014178937core:ListedExchangeTraded2023-06-3014178937core:UnlistedNon-exchangeTraded2023-06-3014178937core:ShareCapital2023-06-3014178937core:SharePremium2023-06-3014178937core:RevaluationReserve2023-06-3014178937core:OtherReservesSubtotal2023-06-3014178937core:RetainedEarningsAccumulatedLosses2023-06-3014178937core:AfterOneYear2024-04-012025-03-3114178937core:WithinOneYear2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3114178937core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3114178937core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3114178937core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3114178937core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3114178937core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3114178937core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3114178937core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3114178937core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3114178937core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3114178937core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3114178937core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3114178937bus:Director12024-04-012025-03-3114178937bus:Director22024-04-012025-03-3114178937bus:Director32024-04-012025-03-3114178937bus:Director42024-04-012025-03-31

PRIMARY CARE DEVELOPMENT HARINGEY LTD

Registered Number
14178937
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

PRIMARY CARE DEVELOPMENT HARINGEY LTD
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Beeley-Fox, Timothy Giles Crispin
Hamlyn, Charlotte Louise, Dr
Patel, Sheena, Dr
Williams, Catherine Eugenie Goodall

Registered Address

48 Station Road
London
N22 7TY

Registered Number

14178937 (England and Wales)
PRIMARY CARE DEVELOPMENT HARINGEY LTD
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors3982,6362,032,696
Cash at bank and on hand2,561,6431,200,614
3,544,2793,233,310
Creditors amounts falling due within one year4(3,544,054)(3,233,292)
Net current assets (liabilities)22518
Total assets less current liabilities22518
Net assets22518
Capital and reserves
Profit and loss account22518
Reserves22518
The financial statements were approved and authorised for issue by the Board of Directors on 4 December 2025, and are signed on its behalf by:
Hamlyn, Charlotte Louise, Dr
Director
Registered Company No. 14178937
PRIMARY CARE DEVELOPMENT HARINGEY LTD
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by guarantee without share capital and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Functional and presentation currency
The financial statements are presented in sterling and this is the functional currency of the company.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for goods supplied and services rendered, stated net of discounts and of Value Added Tax. The company recognises revenue when the amount of revenue can be measured reliably, when it is probable that future economic benefits will flow to the entity and when specific criteria have been met as described below.
Revenue from rendering of services
Revenue from provision of services rendered in the reporting period is recognised when the outcome of a transaction for the rendering of services can be estimated reliably in terms of revenue, costs and its stage of completion of the specific transaction at the end of the reporting period. The stage of completion is determined on the basis of the actual completion of a proportion of the total services to be rendered. When the outcome of a service contract cannot be estimated reliably the company only recognises revenue to the extent of the recoverable expenses recognised.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year4949
3.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables300,7151,469,708
Other debtors227,33587,873
Prepayments and accrued income454,586475,115
Total982,6362,032,696
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables1,107,713815,293
Taxation and social security49-
Accrued liabilities and deferred income2,436,2922,417,999
Total3,544,0543,233,292
5.Change in reporting period and impact on comparability
During the previous financial year, the company changed its year-end from 30 June 2024 to 31 March 2024 to align the company’s financial year with that of Haringey GP Group Limited. As a result of this change, the financial statements presented for the previous period cover a shorter reporting period of 9 months from 01 July 2023 to 31 March 2024. Impact on Comparability The change in the reporting period affects the comparability of the financial statements. The financial information for the previous period is not directly comparable to the current year, which covers a full fiscal year from 1 April 2024 to 31 March 2025.